We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+20.63%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$954M
AUM Growth
-$18.2M
Cap. Flow
-$125M
Cap. Flow %
-13.14%
Top 10 Hldgs %
58.8%
Holding
50
New
7
Increased
9
Reduced
5
Closed
16

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$48.8M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$32.9M
3
HCA icon
HCA Healthcare
HCA
+$29.3M
4
AZN icon
AstraZeneca
AZN
+$25.1M
5
A icon
Agilent Technologies
A
+$23.6M

Top Sells

Rank Stock Value
1
VHS
VANGUARD HEALTH SYS INC COM STK (DE)
VHS
+$41.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31M
3
AGN
Allergan plc
AGN
+$25.2M
4
UHS icon
Universal Health Services
UHS
+$16.7M
5
UNH icon
UnitedHealth
UNH
+$13.1M

Sector Composition

Rank Sector Weight
1 Healthcare 77.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$75.6M 7.92%
2,000,000
+1,800,000
+900% +$70.2M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$40.4B
$75.6M 7.92%
2,000,000
+1,250,000
+167% +$48.8M
VTRS icon
3
Viatris
VTRS
$20.8B
$72.5M 7.6%
1,900,000
+100,000
+6% +$3.52M
ELV icon
4
Elevance Health
ELV
$81.5B
$71.1M 7.45%
850,000
+50,000
+6% +$4.29M
DGX icon
5
Quest Diagnostics
DGX
$26B
$49.4M 5.18%
800,000
– –
VOLC
6
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$47.2M 4.95%
1,975,000
-225,000
-10% -$4.79M
MASI
7
DELISTED
Masimo
MASI
$46.6M 4.89%
1,750,000
– –
HOLX
8
DELISTED
Hologic
HOLX
$46.5M 4.87%
2,250,000
+250,000
+13% +$5.32M
CAH icon
9
Cardinal Health
CAH
$53.7B
$39.1M 4.1%
750,000
– –
HUM icon
10
Humana
HUM
$43.9B
$37.3M 3.91%
400,000
– –
MAKO
11
DELISTED
MAKO SURGICAL CORP COM
MAKO
$35.4M 3.71%
1,200,000
-600,000
-33% -$9.14M
CNMD icon
12
CONMED
CNMD
$1.3B
$34M 3.56%
1,000,000
– –
MNK
13
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$33.1M 3.47%
+750,000
New +$32.9M
HCA icon
14
HCA Healthcare
HCA
$88.4B
$32.1M 3.36%
+750,000
New +$29.3M
GIVN
15
DELISTED
GIVEN IMAGING LTD
GIVN
$28.8M 3.02%
1,500,000
– –
AZN icon
16
AstraZeneca
AZN
$269B
$26M 2.72%
+500,000
New +$25.1M
A icon
17
Agilent Technologies
A
$39.6B
$25.6M 2.69%
+699,000
New +$23.6M
SRPT icon
18
Sarepta Therapeutics
SRPT
$1.64B
$23.6M 2.48%
+500,000
New +$19.3M
WMGI
19
DELISTED
Wright Medical Group Inc
WMGI
$18.5M 1.94%
711,000
-139,000
-16% -$3.63M
ANGO icon
20
AngioDynamics
ANGO
$605M
$17.5M 1.84%
1,327,500
– –
NVAX icon
21
Novavax
NVAX
$1.21B
$14.9M 1.56%
235,550
+75,000
+47% +$4.22M
ARWR icon
22
Arrowhead Research
ARWR
$12.1B
$14.2M 1.49%
2,499,999
-614,755
-20% -$2.36M
DSCI
23
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$11.8M 1.23%
950,000
– –
GNMK
24
DELISTED
GenMark Diagnostics, Inc
GNMK
$11.5M 1.21%
950,000
– –
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11.5M 1.21%
800,000
– –
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Camber Capital Management held 50 positions worth $954M, down 1.9% from $972M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Camber Capital Management withdrew a net $125M in Q3 2013, closing 16 positions and reducing 5 holdings. Its most notable exit was VANGUARD HEALTH SYS INC COM STK (DE), an estimated $41.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 68% a quarter earlier.

Against the trend, Camber Capital Management opened a new position in MALLINCKRODT PUBLIC LIMITED COMPANY worth $33.1M.

  • Camber Capital Management's largest Q3 2013 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 750,000 shares worth $33.1M.
  • Camber Capital Management added most to Teva Pharmaceuticals in Q3 2013, an estimated $48.8M increase.
  • Camber Capital Management's biggest Q3 2013 reduction was INTERMUNE INC, cutting an estimated $11.9M.
  • Camber Capital Management fully exited VANGUARD HEALTH SYS INC COM STK (DE) in Q3 2013, selling an estimated $41.5M.
  • Camber Capital Management's ten largest holdings make up 59% of its $954M portfolio in Q3 2013.
  • Camber Capital Management opened 7 new positions and closed 16 in Q3 2013.
  • Camber Capital Management's portfolio value fell 1.9% quarter-over-quarter to $954M.

Based on Camber Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.